Skip to main content
. 2021 Sep 6;22(5):1263. doi: 10.3892/etm.2021.10698

Figure 1.

Figure 1

Primary biological drugs used to treat severe persistent asthma according to T2 biomarker profile. T2, type 2; FeNo, fractional exhaled nitric oxide; s.c., subcutaneous; Eos, eosinophils; i.v., intravenous; OCS, oral corticosteroid.